Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $827 | Backorder | |
5 mg | $2,480 | Backorder |
Description | Patisiran sodium is a double-stranded small interfering RNA (siRNA) that selectively targets a specific sequence within the transthyretin (TTR) messenger RNA (mRNA). By doing so, it effectively blocks the hepatic synthesis of both mutant and wild-type TTR. Patisiran sodium has significant applications in the field of hereditary TTR amyloidosis research. |
In vitro | Patisiran sodium induces degradation of transthyretin (TTR) through RNA interference, leading to decreased serum TTR protein levels and a reduction in tissue TTR protein deposits. It achieves this by selectively targeting a conserved sequence in the 3' untranslated region of both mutant and wild-type TTR messenger RNA[2]. |
Cas No. | 1386913-72-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.